Video wird geladen...
Video konnte nicht geladen werden
ImmunityBio reported that median overall survival has not yet been reached in patients with recurrent or progressive glioblastoma treated with a chemo-free ANKTIVA® + CAR-NK-based regimen. As recent American Cancer Society data shows that brain cancer is now the third leading cause of cancer-related death among adults ages 20–49,... show more
107,673 Aufrufe • vor 8 Monaten •via X (Twitter)
0 Kommentare
Keine Kommentare verfügbar
Kommentare vom Original-Post werden hier angezeigt
